Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Development and validation of a patient self-assessment score for diabetes risk.

Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI, Kern LM.

Ann Intern Med. 2009 Dec 1;151(11):775-83. doi: 10.7326/0003-4819-151-11-200912010-00005.

2.

A simple screening score for diabetes for the Korean population: development, validation, and comparison with other scores.

Lee YH, Bang H, Kim HC, Kim HM, Park SW, Kim DJ.

Diabetes Care. 2012 Aug;35(8):1723-30. doi: 10.2337/dc11-2347.

3.

Development of a screening score for undiagnosed diabetes and its application in estimating absolute risk of future type 2 diabetes in Japan: Toranomon Hospital Health Management Center Study 10 (TOPICS 10).

Heianza Y, Arase Y, Saito K, Hsieh SD, Tsuji H, Kodama S, Tanaka S, Ohashi Y, Shimano H, Yamada N, Hara S, Sone H.

J Clin Endocrinol Metab. 2013 Mar;98(3):1051-60. doi: 10.1210/jc.2012-3092.

PMID:
23393174
4.

Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010.

Selvin E, Parrinello CM, Sacks DB, Coresh J.

Ann Intern Med. 2014 Apr 15;160(8):517-25. doi: 10.7326/M13-2411.

5.

Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population.

Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr.

J Gen Intern Med. 2008 Sep;23(9):1346-53. doi: 10.1007/s11606-008-0661-6.

6.

Random blood glucose: a robust risk factor for type 2 diabetes.

Bowen ME, Xuan L, Lingvay I, Halm EA.

J Clin Endocrinol Metab. 2015 Apr;100(4):1503-10. doi: 10.1210/jc.2014-4116.

7.

National patterns in diabetes screening: data from the National Health and Nutrition Examination Survey (NHANES) 2005-2012.

Kiefer MM, Silverman JB, Young BA, Nelson KM.

J Gen Intern Med. 2015 May;30(5):612-8. doi: 10.1007/s11606-014-3147-8.

8.

Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study.

Zhang Y, Sun J, Pang Z, Gao W, Sintonen H, Kapur A, Qiao Q.

Prim Care Diabetes. 2013 Dec;7(4):275-82. doi: 10.1016/j.pcd.2013.08.003.

PMID:
24021478
9.

Development and validation of a Diabetes Risk Score for screening undiagnosed diabetes in Sri Lanka (SLDRISK).

Katulanda P, Hill NR, Stratton I, Sheriff R, De Silva SD, Matthews DR.

BMC Endocr Disord. 2016 Jul 25;16(1):42. doi: 10.1186/s12902-016-0124-8.

10.

Utility of the U.S. Preventive Services Task Force criteria for diabetes screening.

Casagrande SS, Cowie CC, Fradkin JE.

Am J Prev Med. 2013 Aug;45(2):167-74. doi: 10.1016/j.amepre.2013.02.026.

11.

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD.

Diabetes Care. 1998 Apr;21(4):518-24.

PMID:
9571335
12.

A simple Chinese risk score for undiagnosed diabetes.

Gao WG, Dong YH, Pang ZC, Nan HR, Wang SJ, Ren J, Zhang L, Tuomilehto J, Qiao Q.

Diabet Med. 2010 Mar;27(3):274-81. doi: 10.1111/j.1464-5491.2010.02943.x.

PMID:
20536489
13.

Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.

Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE.

Diabetes Care. 2000 Feb;23(2):187-91. Erratum in: Diabetes Care 2000 Jun;23(6):876.

14.

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.

Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR; CDC CKD Surveillance Team..

Clin J Am Soc Nephrol. 2010 Apr;5(4):673-82. doi: 10.2215/CJN.07891109.

15.
16.

Tool to assess likelihood of fasting glucose impairment (TAG-IT).

Koopman RJ, Mainous AG 3rd, Everett CJ, Carter RE.

Ann Fam Med. 2008 Nov-Dec;6(6):555-61. doi: 10.1370/afm.913.

17.

Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004.

Whaley-Connell AT, Sowers JR, McFarlane SI, Norris KC, Chen SC, Li S, Qiu Y, Wang C, Stevens LA, Vassalotti JA, Collins AJ; Kidney Early Evaluation Program Investigators..

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S21-9. doi: 10.1053/j.ajkd.2007.12.013.

PMID:
18359404
18.

Performance of recommended screening tests for undiagnosed diabetes and dysglycemia.

Rolka DB, Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM.

Diabetes Care. 2001 Nov;24(11):1899-903. Erratum in: Diabetes Care 2002 Feb;25(2):413.

PMID:
11679454
19.

Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.

Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, Wu P, Teng X, Dong Y, Zhou Jw, Xu H, Zheng J, Li S, Tao T, Hu Y, Jia Y.

Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2.

PMID:
19760291
20.

CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen SC, Norris KC, McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT; Kidney Early Evaluation Program Investigators..

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45. doi: 10.1053/j.ajkd.2007.12.017.

PMID:
18359407

Supplemental Content

Support Center